Anatara Financial Statements From 2010 to 2025
| ANR Stock | 0.01 0 12.50% |
Gross Profit | Market Capitalization 1.5 M | Enterprise Value Revenue 2.1812 | Revenue | Earnings Share (0.01) |
Anatara Lifesciences Total Revenue |
|
Check Anatara Lifesciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Anatara Lifesciences' main balance sheet or income statement drivers, such as Interest Expense of 2.9 K, Selling General Administrative of 1.6 M or Total Revenue of 0.0, as well as many indicators such as . Anatara financial statements analysis is a perfect complement when working with Anatara Lifesciences Valuation or Volatility modules.
Anatara | Select Account or Indicator |
Anatara Lifesciences Balance Sheet | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Anatara Lifesciences Income Statement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Anatara Lifesciences Cash Flow Statement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Anatara Fundamental Market Drivers
| Cash And Short Term Investments | 982.1 K |
About Anatara Lifesciences Financial Statements
Anatara Lifesciences shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Anatara Lifesciences investors may analyze each financial statement separately, they are all interrelated. The changes in Anatara Lifesciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on Anatara Lifesciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | -23.8 K | -24.9 K | |
| Cost Of Revenue | 674 K | 707.7 K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Anatara Stock Analysis
When running Anatara Lifesciences' price analysis, check to measure Anatara Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anatara Lifesciences is operating at the current time. Most of Anatara Lifesciences' value examination focuses on studying past and present price action to predict the probability of Anatara Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anatara Lifesciences' price. Additionally, you may evaluate how the addition of Anatara Lifesciences to your portfolios can decrease your overall portfolio volatility.